Search
Search Constraints
You searched for: Date 2022 Author/Creator Hunger, MatthiasLimit your search
- Hunger, Matthias [remove] 1
- 616.99424 1
- ATE atezolizumab -- BSC best supportive care -- CI confidence interval -- CNS central nervous system -- DUR durvalumab -- ECOG PS Eastern Co-operative Oncology Group performance status -- EC European Commission -- EGFR epidermal growth factor receptor -- FDA Food and Drug Administration -- HR hazard ratio -- ICI immune checkpoint inhibitors -- IO immunotherapy -- NIV nivolumab -- NSCLC non-small cell lung cancer -- OS overall survival -- PD-L1 programmed death-ligand 1 -- PD-1 programmed death receptor-1 -- PEM pembrolizumab -- PFS progression-free survival -- PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses -- PS performance status -- RCT randomized controlled trials -- RWE real-world evidence -- SLR systematic literature review 1
- Electronic journals 1
- Lung Neoplasms -- Abstracts 1
- Lung Neoplasms -- Periodicals 1
- Lungs -- Cancer 1
- Lungs -- Cancer -- Periodicals 1
- NSCLC -- Real-world evidence -- Immunotherapy -- Overall survival -- Effectiveness -- Nivolumab 1
- Periodicals 1
- Poumons -- Cancer -- Périodiques 1